Use of induracin, a long-acting nicotinic acid formulation, to correct atherogenetic dyslipidemias

Autor:	Rafael Oganov, Kiseleva, N. G., Aronov, D. M., Akhmedzhanov, N. M., Olferyev, A. M., Kiseleva, N. S., Perova, N. V.
Zdroj:	Scopus-Elsevier
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::45e8e17c97205aa5a107b43e65ab2e3f http://www.scopus.com/inward/record.url?eid=2-s2.0-0027793174&partnerID=MN8TOARS Zobrazit plný text záznamu